Crown disease 19 epidemic
Michaelxin sort out
Studies have pointed out that vaccine addition agents can help prevent crown disease and symptoms.The 50 -year -old and above inocus Pfizer -Biontech or Modner and other coronary vaccines made by messenger ribonucleic acid (MRNA) technology.
(Chicago Composite Electric) The three studies from the US Centers for Disease Control and Prevention show that the third dose of a messenger ribonucleic acid crown disease is the opposition to Omiko's variant variantsThe key to the strains can prevent 90%of the effectiveness of hospitalization after infection.
These studies have pointed out that vaccination additional additions can help prevent crown disease and symptoms of the occurrence of infection.The 50 -year -old and above inocus Pfizer -Biontech or Modner and other coronary vaccines made by messenger ribonucleic acid (MRNA) technology.
Director of the American Disease Control and Prevention Center (CDC) Valenzki said at the White House press conference the day before yesterday: "Those who have been vaccinated in time are in accordance with the additional vaccination and have done soPeople, they have the strongest resistance to Omikon and hospitalization. "
This is the first time that CDC can play a large -scale research on the role of vaccine additions on Omikon poison strains.Omikon is currently the mainstream strain spread in the United States, accounting for 99%of new cases.
One of the studies of CDCs from August 26 last year to January 5 this year. The research target is more than 300,000 cases processed by hospitals and clinic emergency departments in 10 states in the United States.The results showed that during the previous Dedorta's epidemic, after six months of vaccination of the second dose of vaccination, the effectiveness of the prevention of severe illnesses would be reduced from 90%to 81%, but after two weeks after the third pins, the resistance will rise to 94%.
In the Omiko out of the epidemic, the second dose for the second dose for more than six months, the effect of preventing severe illnesses will be reduced from 81%to 57%, and one dose of multiple vaccination will rise to 90%.
The risk of death of those who have not been vaccinated are 50 times the vaccination
This has also been found that the risk of dying from crown diseases who have not been vaccinatedIt is equivalent to 50 times the vaccination.
Another study of CDC was conducted from December 10 last year to January 1 this year. The research target was 23,391 patients with Delta or Omiko.The results also showed that compared with those who only vaccinated the MRNA vaccine or unagittering, those who had been vaccinated with three doses were more resistant.
The previous research of the UK showed that the antibodies produced by the crown vaccine additional agent will begin to decline after 10 months, but it is unclear how long the effectiveness of the three -dose MRNA vaccine is sustainable.
According to the latest data of CDC, the United States has only 39.3%, that is, 82.5 million people who have vaccinated two doses of coronary disease have been added to the third additional addition.
At the same time, another study jointly conducted by researchers in Brazil and Oxford University in the United Kingdom found that after the two doses of the Cosach vaccine, an additional MRNA vaccine can be added to effectively prevent Omikk prevention to prevent Omeck prevention.Rong.
The main Chinese medicine and Chinese medicine coronary vaccine uses more traditional surplus technologies.
This joint research team conducted a research in Brazil in Brazil to conduct an adult who vaccinated the Kochi vaccine in Brazil; the results found that although the addition of the antibody increased by the vaccine of the Kochi vaccine after 28 days, the vaccination Pfizer, Asna, Asle, AsleThe protective effect of Likan or Johnson & Johnson's vaccine additional agent is much significant.
This research report published by Liuye Dao the day before yesterday states that compared with the third dose of the Kochixing vaccine, the additional mixing agent can produce a strongerAntibody protection.
Among them, Pfizer Additional agents can increase the antibody by 152 times, which is the strongest among various additional additions.For the third acupuncture vaccine, the antibody can increase by 12 times.
The leader of the Oxford University Vaccine Research Team, Brazil, said: "These data can be used as a reference for low -income countries, which will help them formulate the best and affordable additional vaccination plan."
